--- title: 'Funding Daily Summary: What Happened on November 10, 2026' headline: Delix raises $100 million to advance zalsupindole description: Oyster raised $60 million for tau-targeting brain drugs, while Neobe secured $6.8 million for its engineered-bacteria cancer program. url: https://thebench.bio/news/funding/2026-11-10 topic: funding date: '2026-11-10' covers: - '2026-11-10' date_published: '2026-11-10T12:02:55Z' date_modified: '2026-11-10T12:02:55Z' tags: - Funding - Industry sources: 3 publisher: TheBench.Bio --- # Funding Daily Summary: What Happened on November 10, 2026 **Delix raises $100 million to advance zalsupindole** Oyster raised $60 million for tau-targeting brain drugs, while Neobe secured $6.8 million for its engineered-bacteria cancer program. ## Today in brief Delix Therapeutics raised $100 million in a Series C and plans to move zalsupindole toward a placebo-controlled Phase II trial in early 2027. [1] Oyster raised $60 million for tau-targeting brain drugs. Neobe raised $6.8 million to advance its engineered-bacteria cancer program. [2] [3] ## Also worth knowing - Oyster raised $60 million for brain drugs targeting tau. The company says its adaptation of protein-degradation technology may help break down the protein. [2] - Neobe Therapeutics raised $6.8 million in seed funding, led by ARC Ventures, to advance NEO22 through preclinical development. The company targets an investigational new drug application in 2028. [3] - Delix Therapeutics raised an oversubscribed Series C co-led by JJDC and the Dementia Discovery Fund. The company plans to advance zalsupindole toward a placebo-controlled Phase II trial in early 2027. [1] ## The day in numbers - **$100 million**: Delix Therapeutics' Series C financing [1] - **$60 million**: Oyster's funding for tau-targeting brain drug programs [2] - **$6.8 million**: Neobe Therapeutics' seed round for its cancer program [3] ## Sources 1. [Delix Therapeutics raises $100m for zalsupindole development](), Pharmaceutical Technology, 2026-11-10 2. [London biotech Oyster harvests $60M for tau-targeting brain drugs](), BioPharma Dive, 2026-11-10 3. [Neobe raises $6.8M to break tumor barriers with bacteria](), European Biotechnology, 2026-11-10 --- TheBench.Bio wrote this from the reporting cited above, with a language model drafting and editing. [1]: [2]: [3]: